generic

Takeda nets $660m from product selloff to Germany’s Stada

https://pharmaphorum.com/news/takeda-nets-660m-from-product-selloff-to-germanys-stada/

Mylan up on OK for generic of Lilly’s $2bn cancer drug Alimta

https://pharmaphorum.com/news/mylan-up-on-ok-for-generic-of-lillys-2bn-cancer-drug-alimta/

Hikma buys potential Epipen rival from troubled Insys

https://pharmaphorum.com/news/hikma-buys-potential-epipen-generic-from-insys/

US court invalidates key patent on J&J’s Zytiga

https://pharmaphorum.com/news/court-invalidates-key-patent-jjs-zytiga/

Concordia hiked drug price by 6,000%, says UK watchdog

https://pharmaphorum.com/news/concordia-drug-price-cma/

Hikma in dispute with FDA over Advair generic

https://pharmaphorum.com/news/hikma-dispute-fda-advair-generic/

Judge throws out Allergan patents, criticises Native American tribe deal

https://pharmaphorum.com/news/allergan-dry-eye-drug-facing-generic-threat/

Copaxone first on FDA’s list for faster complex generic approvals

https://pharmaphorum.com/news/mylan-targets-teva-ms-blockbuster-copaxone-us/

EU authorities accuse Teva of breaking competition rules

https://pharmaphorum.com/news/eu-teva-competition-rules/

1 2 3 4

Close in 10 seconds

Pharmaphorum.com

Search